SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

NONJA CRYPTO is experiencing heightened interest as its passionate community rallies around the Injective ($INJ) ecosystem's growth, driven by recent network developments like the EVM mainnet launch and anticipated INJ ETFs. Many perceive $NONJA as a high-leverage opportunity on Injective's trajectory, emphasizing its strong community and robust liquidity as key factors for significant future gains.

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sutro Biopharma Inc

Sutro Biopharma is trending due to its recent reverse stock split, which helped it regain Nasdaq listing compliance, alongside a major corporate restructuring and workforce reduction. The community is actively debating the deprioritization of its lead asset, Luvelta, and the company's strategic pivot towards its next-generation ADC programs. Many investors are keenly focused on the potential for new partnerships for Luvelta and upcoming pipeline milestones, given the company's substantial cash reserves within the competitive biotech sector.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is gaining significant attention, propelled by its AI-powered Athena platform and recent Marigold acquisition. The community is highly optimistic, discussing its perceived undervaluation and anticipating a substantial rerating as GAAP profitability nears and its leadership in AI-driven MarTech with first-party data is increasingly recognized. This positions Zeta as a key player in the evolving digital advertising landscape.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing a parabolic surge, primarily driven by imminent Chinese export restrictions on silver and a notable increase in industrial demand for green technology, microchips, and AI data centers. The community is fiercely debating whether this represents a historic re-pricing following decades of suppression and dwindling physical supply, or if it's an unsustainable speculative rally with bears warning of a sharp correction.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as its dedicated community, often referring to themselves as the 'infected army,' is vigorously promoting its viral growth and a robust '2026 agenda' for expansion. Messages emphasize PMV's 'pure meme supremacy,' portraying it as a resilient and fun-focused project poised for significant momentum within the Solana ecosystem and the broader meme coin market.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending following its acquisition of Melt Pharmaceuticals and ahead of its Investor Day, where the company is expected to detail a path to significant revenue growth. Community sentiment is highly bullish, driven by anticipated Vevye market share expansion through major insurance formulary wins and speculation about short covering fueling further price momentum. Many investors believe the stock is currently undervalued, positioning it for substantial long-term gains within the ophthalmic sector.

MicroAlgo, Inc. operates as a holding company, which engages in the development and application of bespoke central processing algorithms. Its services include algorithm optimization, accelerating computing power without the need for hardware upgrades, lightweight data processing, and data intelligence. The company was founded May 14, 2018 and is headquartered in New York, NY.

MicroAlgo Inc

MicroAlgo Inc. is trending with highly polarized sentiment, primarily driven by concerns over potential dilution and further reverse splits, while optimists highlight its undervalued position in AI and quantum technology, anticipating a significant short squeeze. The community eagerly awaits upcoming financial disclosures and monitors reported trading restrictions on certain platforms, adding to the stock's speculative nature amidst low volume.

The SUN.io platform is TRON's first one-stop platform that supports stablecoin swap, token mining and self-governance. After the redenomination, the new SUN token, as a multifunctional governance token on the SUN platform (similar to the CRV token of Curve DAO and the EPS token of Ellipsis), will grant token holders various rights and benefits such as the voting and governance right in the community, value capture, staking rewards, etc..

Sun Token

SUN is trending as its ongoing attempts to break through significant technical resistance levels are actively debated by the community, fueling speculation about its market direction. Many within the Tron ecosystem highlight SUN's perceived strength, with discussions also circling potential exchange-related developments and strong bullish sentiment for its future performance.

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers' enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.

Nutanix Inc - Ordinary Shares - Class A

Nutanix Inc 

Nutanix is actively discussed after announcing a significant accelerated share repurchase program, sparking community debate about its valuation. Many believe the stock is oversold and poised for a rebound, highlighting its continued success in capturing market share from VMware amid industry shifts. However, some investors remain cautious, citing recent volatility and past market reactions to earnings reports.

Caledonia Mining Corp. Plc engages in the exploration, development, and production of gold and other precious metals from its mineral properties. Its projects include Blanket Gold Mine and Maligreen. The company was founded on February 5, 1992 and is headquartered in St. Helier, the United Kingdom.

Caledonia Mining Corporation Plc

Caledonia Mining is trending amid revised gold royalty regulations in Zimbabwe that are easing tax concerns, alongside a sustained surge in global gold prices to new all-time highs. The community is actively discussing the company's robust profitability, growing cash flow, and the highly anticipated transformative potential of its Bilboes project, expected to significantly boost future production. Many investors believe the stock's current valuation does not yet fully reflect these strong fundamentals and the broader gold market tailwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a report on Saturday...

Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital

D. Boral Capital reaffirmed a "buy" rating and issued a $10.00 price target on shares of Anixa Biosciences in a research note on Friday...

Anixa Biosciences Shares Jump Over 15% In After-Hours Trading Here's Why

Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast cancer vaccine.read more...

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants Anixa Biosciences Announces...

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025...

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research

Zacks Research downgraded Anixa Biosciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...

Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization

Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future...

Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s

Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s...

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11...

Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic

Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic PR Newswire SAN JOSE...

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Current Price	$3.20
Prev Close	$3.42
Open	$3.41
Dividend Yield	0.00%
50-Day Moving Average	$4.17
Beta	1.19
Avg. Volume	166,075.79
PE Ratio	-9.29

52-Week High	$5.46
52-Week Low	$2.07
Market Capitalization	$112.58M
EPS (Annual)	-$0.3936
Price to Book	6.33
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ANIX
Anixa Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIX News

ANIXAnixa Biosciences Inc